Effect of Pranayama & Yogasana on HIV/AIDS -3


Previous studies and research demonstrate that there will be very positive outcomes in alternative medicine research like Yoga to evaluate beneficial effects of Yoagasana (Yoga Postures) and Pranayama [Voluntary regulated Yoga Breathing] in patients with HIV infection.


1. Marx, J. L. (1982). "New disease baffles medical community". Science 217 (4560): 618–621. PubMed. 

2. Divisions of HIV/AIDS Prevention (2003). HIV and Its Transmission. Centers for Disease Control & Prevention. Retrieved on 2006-05-23.

3. San Francisco AIDS Foundation (2006-04-14). How HIV is spread. Retrieved on 2006-05-23.

4. Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., Sharp, P. M. and Hahn, B. H. (1999). "Origin of HIV-1 in the Chimpanzee Pan troglodytes troglodytes". Nature 397 (6718): 436–441. PubMed doi:10.1038/17130. 

5. UNAIDS (2006). "Overview of the global AIDS epidemic", 2006 Report on the global AIDS epidemic (PDF).

  6. Palella, F. J. Jr, Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman and D. J., Holmberg, S. D. (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators". N. Engl. J. Med 338 (13): 853–860. PubMed.

7. Morgan, D., Mahe, C., Mayanja, B., Okongo, J. M., Lubega, R. and Whitworth, J. A. (2002). "HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?". AIDS 16 (4): 597–632. PubMed. 

8. Clerici, M., Balotta, C., Meroni, L., Ferrario, E., Riva, C., Trabattoni, D., Ridolfo, A., Villa, M., Shearer, G.M., Moroni, M. and Galli, M. (1996). "Type 1 cytokine production and low prevalence of viral isolation correlate with long-term non progression in HIV infection". AIDS Res. Hum. Retroviruses. 12 (11): 1053–1061. PubMed. 

9. Morgan, D., Mahe, C., Mayanja, B. and Whitworth, J. A. (2002). "Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study". BMJ 324 (7331): 193–196. PubMed.

  9. Gendelman, H. E., Phelps, W., Feigenbaum, L., Ostrove, J. M., Adachi, A., Howley, P. M., Khoury, G., Ginsberg, H. S. and Martin, M. A. (1986). "Transactivation of the human immunodeficiency virus long terminal repeat sequences by DNA viruses". Proc. Natl. Acad. Sci. U. S. A. 83 (24): 9759–9763. PubMed. 

10. Bentwich, Z., Kalinkovich., A. and Weisman, Z. (1995). "Immune activation is a dominant factor in the pathogenesis of African AIDS.". Immunol. Today 16 (4): 187–191. PubMed. 

11. Tang, J. and Kaslow, R. A. (2003). "The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy". AIDS 17 (Suppl 4): S51–S60. PubMed.

  12. Quiñones-Mateu, M. E., Mas, A., Lain de Lera, T., Soriano, V., Alcami, J., Lederman, M. M. and Domingo, E. (1998). "LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression". Virus Research 57 (1): 11–20. PubMed.

  13. Campbell, G. R., Pasquier, E., Watkins, J., Bourgarel-Rey, V., Peyrot, V., Esquieu, D., Barbier, P., de Mareuil, J., Braguer, D., Kaleebu, P., Yirrell, D. L. and Loret E. P. (2004). "The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis". J. Biol. Chem. 279 (46): 48197–48204. PubMed.

  14. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, Nakiyingi J, Rutebemberwa A, Morgan D, Weber J, Gilks C, Whitworth J. (2002). "Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda". J. Infect. Dis. 185 (9): 1244–1250. PubMed.

  16. Saraswathy, A. (1994b) - Traditional medicine in the management of Aids, Ancient Science of Life 14, 1/2, 91-98.

17. Holmes, C. B., Losina, E., Walensky, R. P., Yazdanpanah, Y., Freedberg, K. A. (2003). "Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa". Clin. Infect. Dis. 36 (5): 656–662. PubMed.

  18. Newshan, Gayle. Transcending the physical: Spiritual aspects of pain in patients with HIV and/or cancer. Journal of Advanced Nursing, Dec 1998, 28(6):1236-1241.

19. Standish, L. J., K. B. Greene, S. Bain, C. Reeves, F. Sanders, R. C. Wines, P. Turet, J. G. Kim, and C. Calabrese. Alternative medicine use in HIV-positive men and women: Demographics, utilization patterns and health status. AIDS Care, Apr 2001, 13(2):197-208. Author email: ljs@bastyr.edu. PMID: 11304425.

20. Sowell, Richard; Moneyham, Linda; Hennessy, Michael; Guillory, Joyce; Demi, Alice; Seals, Brenda, Spiritual Activities as a Resistance Resource for Women With Human Immunodeficiency Virus., Nursing Research. 49(2):73-82, March/April 2000.

21. Koar, William. Meditation, T-cells, anxiety, depression and HIV infection. Subtle Energies and Energy Medicine Journal, 1995, 6(1).

22. Sicher, Fred. Elisabeth Targ, Dan Moore II, and Helene S. Smith. A randomized doubleblind study of the effect of distant healing in a population with advanced aids: Report of a small scale study. Subtle Energies and Energy Medicine Journal, 1998, 9(2).

Acharya Balkrishna is Head, R & D Activities, Divya Yog Mandir Trust, Haridwar; Avnish Upadhyay is Senior Research Scientist, Department Of Ayurved Research & Development, Divya Yog Mandir Trust & Ruchita T Upadhyay is Yog Teacher & Human Resource Personnel, Patanjali Yog Peeth, Haridwar, Haridwar

    * Related Articles :